World's Best Scientists 2026 revealed!
Dominique Costagliola

Dominique Costagliola

Award Badge
Medicine
France
2023

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
43463
World Ranking
1013
National Ranking
30

Medicine

D-Index
107
Citations
44690
World Ranking
6216
National Ranking
180

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Dominique Costagliola is affiliated with Inserm in France and has contributed extensively to the field of medicine, particularly focusing on infectious diseases. Their research outputs span a range of topics including HIV/AIDS, COVID-19, and related clinical interventions.

The main fields of study for Dominique Costagliola include Medicine, with significant specialization in the following subfields:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Neurology
  • Oncology

Key research topics covered in their work are:

  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Long-Term Effects of COVID-19
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments

Dominique Costagliola is a frequent collaborator with several researchers, including:

  • Lambert Assoumou
  • Florence Ader
  • Maya Hites
  • Karine Lacombe
  • Christine Katlama

Their recent papers demonstrate involvement in major clinical trials and observational studies related to infectious diseases and COVID-19 treatments. Selected publications include:

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, 2021, The Lancet Infectious Diseases
  • Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study, 2022, The Lancet HIV
  • Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials, 2023, The Lancet Respiratory Medicine
  • Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design, 2024, The Lancet Infectious Diseases
  • An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19, 2021, Clinical Microbiology and Infection

Their work has been published in several prominent venues, with frequent appearances in:

  • SSRN Electronic Journal
  • Clinical Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • AIDS

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

    Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

    Jorge R. Almeida;David A. Price;David A. Price;Laura Papagno;Zaïna Aït Arkoub

  • Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies

    J Gill;Margaret T May;C Lewden;M Saag

  • Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

    Murielle Mary-Krause;Laurent Cotte;Anne Simon;Maria Partisani

  • Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

    Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang

  • The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

    Maile Ray;Roger Logan;Jonathan A C Sterne;Sonia Hernández-Díaz

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

    Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport

  • Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

    Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua

  • Beyond viral suppression of HIV – the new quality of life frontier

    Jeffrey V. Lazarus;Jeffrey V. Lazarus;Kelly Safreed-Harmon;Simon E. Barton;Dominique Costagliola

  • Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

    Dominique Salmon-Ceron;Charlotte Lewden;Philippe Morlat;Sibylle Bévilacqua

  • Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

    Caroline Besson;Aicha Goubar;Jean Gabarre;Willy Rozenbaum

  • Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

    Charlotte Lewden;Thierry May;Eric Rosenthal;Christine Burty

  • Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

    Marc-Antoine Valantin;Camille Aubron-Olivier;Jade Ghosn;Elisabeth Laglenne

  • Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte

  • Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

    Magid Herida;Murielle Mary-Krause;Régis Kaphan;Jacques Cadranel

  • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

    May M;Sterne Ja;Sabin C;Costagliola D

  • Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4

    Sylvie Lang;Murielle Mary-Krause;Laurent Cotte;Jacques Gilquin

Frequent Co-Authors

Christine Katlama
Christine Katlama Sorbonne University
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Jonathan A C Sterne
Jonathan A C Sterne University of Bristol
Brigitte Autran
Brigitte Autran Sorbonne University
Dominique Salmon
Dominique Salmon Université Paris Cité
Margaret T May
Margaret T May University of Bristol
Amy C. Justice
Amy C. Justice Yale University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Philippe Morlat
Philippe Morlat University of Bordeaux
Caroline Sabin
Caroline Sabin University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible or specialized routes, there are a variety of online degree pathways available. Many students opt for advanced nursing degrees, such as the most affordable DNP programs, which open doors to leadership and clinical practice roles without the need to relocate.

Pharmacy is another popular choice, with the emergence of 3 year online PharmD programs that allow working professionals to advance their careers flexibly.

If you are drawn to the technological side of medicine, healthcare informatics degree programs prepare students to manage patient data and healthcare technology—key skills in the modern healthcare system.

For those looking to enter the workforce more quickly, billing and coding classes online can lead to vital administrative roles in medical facilities, often in under a year.

These alternative online career pathways offer flexibility, affordability, and the opportunity to make a difference in healthcare without the traditional medical school route.

Best Scientists Citing Dominique Costagliola

Trending Scientists